|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.11 CNY | -0.31% |
|
+1.68% | +12.47% |
| Market Cap | 5.3B 783M 683M 632M 592M 1.11B 73.87B 1.12B 7.5B 2.91B 36.36B 2.94B 2.88B 126B | P/E 2024 |
-22.7x | P/E 2025 | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.46B 807M 704M 652M 610M 1.14B 76.17B 1.15B 7.73B 3B 37.49B 3.03B 2.97B 130B | EV / Sales 2024 |
6.46x | EV / Sales 2025 | 31.6x |
| Free-Float |
31.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.31% | ||
| 1 week | +1.68% | ||
| Current month | -10.03% | ||
| 1 month | -24.56% | ||
| 3 months | -17.04% | ||
| 6 months | +31.85% | ||
| Current year | +12.47% |
| 1 week | 65.8 |  | 71.29 |
| 1 month | 65.15 | | 90.19 |
| Current year | 54.9 | | 98.29 |
| 1 year | 25.51 | | 98.29 |
| 3 years | 12.6 | | 98.29 |
| 5 years | 12.6 | | 98.29 |
| 10 years | 12.6 | | 98.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Deng
CEO | Chief Executive Officer | 60 | 2018-11-30 |
Chao Li
DFI | Director of Finance/CFO | 47 | 2017-04-30 |
Fen Jin
DFI | Director of Finance/CFO | 46 | 2017-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Yong Deng
CHM | Chairman | 60 | 2017-11-30 |
Shao Zhong Zhang
BRD | Director/Board Member | 70 | 2020-02-20 |
Qin Deng
BRD | Director/Board Member | 58 | 2020-02-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | +1.68% | +162.87% | +186.06% | 784M | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 317B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 270B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 269B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 191B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.30% | -2.52% | +33.48% | +54.44% | 329.48B | |
| Weighted average by Cap. | -0.79% | -3.66% | +28.01% | +64.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 241M 35.55M 31M 28.71M 26.87M 50.4M 3.35B 50.71M 341M 132M 1.65B 133M 131M 5.73B | 154M 22.78M 19.86M 18.39M 17.22M 32.29M 2.15B 32.49M 218M 84.57M 1.06B 85.5M 83.67M 3.67B |
| Net income | -62.67M -9.26M -8.07M -7.48M -7M -13.13M -874M -13.21M -88.69M -34.37M -430M -34.75M -34.01M -1.49B | -102M -15.09M -13.16M -12.19M -11.41M -21.4M -1.42B -21.53M -145M -56.04M -701M -56.66M -55.44M -2.43B |
| Net Debt | 135M 19.9M 17.35M 16.07M 15.04M 28.21M 1.88B 28.38M 191M 73.88M 924M 74.69M 73.09M 3.21B | 165M 24.38M 21.26M 19.69M 18.43M 34.57M 2.3B 34.78M 234M 90.52M 1.13B 91.52M 89.56M 3.93B |
Employees
497
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 67.11 ¥ | -0.31% | 835,600 |
| 26-06-17 | 67.32 ¥ | -2.87% | 902,900 |
| 26-06-16 | 69.31 ¥ | +0.64% | 1,000,463 |
| 26-06-15 | 68.87 ¥ | +4.35% | 1,381,000 |
| 26-06-12 | 66.00 ¥ | -0.71% | 1,217,805 |
- Stock Market
- Stocks
- 301075 Stock
Select your edition
All financial news and data tailored to specific country editions
